1-4 of 4
Mathew Maurer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of patients with mayo stage IIIb systemic AL amyloidosis treated with daratumumab-based frontline therapy

Free
Simon Zhen, Divaya Bhutani, Mathew Maurer, Karan Wats, Yevgeniy Brailovsky, Michael Hughes, Jai Radhakrishnan, Markus Mapara, Suzanne Lentzsch, Rajshekhar Chakraborty
Journal: Blood
Blood (2025) 146 (Supplement 1): 5740.
https://doi.org/10.1182/blood-2025-5740
Published: 2025
Journal Articles

Shifting symptom profiles and accelerated diagnosis in AL amyloidosis: Findings from ARC community surveys 2022–2024

Free
Sabrina Rebello, Kristen Hsu, Sascha Tuchman, Phaedra Johnson, Brett Sperry, Raymond Comenzo, Lisa Mendelson, Dhruv Kazi, Mathew Maurer
Journal: Blood
Blood (2025) 146 (Supplement 1): 4564.
https://doi.org/10.1182/blood-2025-4564
Published: 2025
Journal Articles

Impact of Light Chain Isotype on Clinical Features and Outcomes in Systemic AL Amyloidosis

Free
Madeleine Hopson, Divaya Bhutani, Shawn M Sarkaria, Mathew Maurer, Jan Griffin, Suzanne Lentzsch, Rajshekhar Chakraborty
Journal: Blood
Blood (2021) 138 (Supplement 1): 4726.
https://doi.org/10.1182/blood-2021-149299
Published: 2021
Journal Articles

Predictors of Survival in De Novo Cardiac Amyloidosis.

Free
Raymond L. Comenzo, MD, Mathew Maurer, MD, Adam Cohen, MD, Hani Hassoun, MD, Ping Zhou, PhD, Ping Lu, PhD, Martin Fleisher, PhD, Daniel Lebovic, MD, Julie Feldstein, MD, Richard Steingart, MD, Stephen D. Nimer, MD
Journal: Blood
Blood (2007) 110 (11): 2870.
https://doi.org/10.1182/blood.V110.11.2870.2870
Published: 2007